Predicting seizure control: Cortical excitability and antiepileptic medication

Annals of Neurology

Volumn 67, Issue 1, 2010, Pages 64-73

  Badawy, Radwa A B ^a,b   Macdonell, Richard A L ^a,b,c   Berkovic, Samuel F ^a,b   Newton, Mark R ^a,b   Jackson, Graeme D ^a,b,c  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVOKED MUSCLE RESPONSE; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BRAIN; COHORT STUDIES; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; EVOKED POTENTIALS, MOTOR; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; SEIZURES; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77649319449     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21806     Document Type: Article

References (41)

1. Forsgren L, Bucht G, Eriksson S, Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996;37:224-229.
2. Hauser WA, Rich SS, Lee JR, et al. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998;338:429-434.
3. Cascino GD. When drugs and surgery don't work. Epilepsia 2008;49(suppl 9):79-84.
4. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
5. Arroyo S, Brodie MJ, Avanzini G, et al. Is refractory epilepsy preventable? Epilepsia 2002;43:437-444.
6. McCormick DA, Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 2001;63:815-846.
7. Hamer HM, Reis J, Mueller HH, et al. Motor cortex excitability in focal epilepsies not including the primary motor area - a TMS study. Brain 2005;128:811-818.
8. Werhahn KJ, Lieber J, Classen J, Noachtar S. Motor cortex excitability in patients with focal epilepsy. Epilepsy Res 2000;41:179-189.
9. Reutens DC, Berkovic SF, Macdonell RA, Bladin PF. Magnetic stimulation of the brain in generalized epilepsy: reversal of cortical hyperexcitability by anticonvulsants. Ann Neurol 1993;34:351-355.
10. Lee HW, Seo HJ, Cohen LG, et al. Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal. Clin Neurophysiol 2005;116:1105-1112.
11. Cantello R, Civardi C, Varrasi C, et al. Excitability of the human epileptic cortex after chronic valproate: a reappraisal. Brain Res 2006;1099:160-166.
12. Kazis DA, Kimiskidis VK, Papagiannopoulos S, et al. The effect of valproate on silent period and corticomotor excitability. Epileptic Disord 2006;8:136-142.
13. Turazzini M, Manganotti P, Del Colle R, et al. Serum levels of carbamazepine and cortical excitability by magnetic brain stimulation. Neurol Sci 2004;25:83-90.
14. Manganotti P, Bongiovanni LG, Zanette G, et al. Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia1999;40:316-321.
15. Ziemann U. TMS and drugs. Clin Neurophysiol 2004;115:1717-1729.
16. Tataroglu C, Ozkiziltan S, Baklan B. Motor cortical thresholds and cortical silent periods in epilepsy. Seizure 2004;13:481-485.
17. Ertas NK, Gul G, Altunhalka A, Kirbas D. Cortical silent period following transcranial magnetic stimulation in epileptic patients. Epileptic Disord 2000;2:137-140.
18. Badawy RA, Curatolo JM, Newton M, et al. Sleep deprivation increases cortical excitability in epilepsy: syndrome-specific effects. Neurology 2006;67:1018-1022.
19. Badawy RA, Curatolo JM, Newton M, et al. Changes in cortical excitability differentiate generalized and focal epilepsy. Ann Neurol 2007;61:324-331.
20. Garvey MA, Gilbert DL. Transcranial magnetic stimulation in children. Eur J Paediatr Neurol. 2004;8:7-19.
21. Hattemer K, Knake S, Reis J, et al. Cyclical excitability of the motor cortex in patients with catamenial epilepsy: a transcranial magnetic stimulation study. Seizure 2006;15:653-657.
22. Smith MJ, Keel JC, Greenberg BD, et al. Menstrual cycle effects on cortical excitability. Neurology 1999;53:2069-2072.
23. Rossini PM, Barker AT, Berardelli A, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994;91:79-92.
24. Oldfield RC. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 1971;9:97-113.
25. Cohen JB. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1969.
26. Sackett DL. Interpretation of diagnostic data: 1. How to do it with pictures. Can Med Assoc J 1983;129:429-432.
27. Loscher W. How to explain multidrug resistance in epilepsy? Epilepsy Curr 2005;5:107-112.
28. Mavroudakis N, Caroyer JM, Brunko E, Zegers de Beyl D. Effects of vigabatrin on motor potentials evoked with magnetic stimulation. Electroencephalogr Clin Neurophysiol 1997;105:124-127.
29. Boroojerdi B. Pharmacologic in.uences on TMS effects. J Clin Neurophysiol 2002;19:255-271.
30. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993;471:501-519.
31. Ziemann U. Pharmacology of TMS. Suppl Clin Neurophysiol 2003;56:226-231.
32. Inghilleri M, Berardelli A, Marchetti P, Manfredi M. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 1996;109:467-472.
33. Valzania F, Strafella AP, Tropeani A, et al. Facilitation of rhythmic events in progressive myoclonus epilepsy: a transcranial magnetic stimulation study. Clin Neurophysiol 1999;110:152-157.
34. Ziemann U, Steinhoff BJ, Tergau F, Paulus W. Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 1998;30:11-30.
35. Mott DD, Lewis DV. The pharmacology and function of central GABAB receptors. Int Rev Neurobiol 1994;36:97-223.
36. Ziemann U, Lonnecker S, Paulus W. Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. Brain 1995;118:1437-1446.
37. Di Lazzaro V, Oliviero A, Tonali PA, et al. Changes in motor cortex excitability in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2004;14:39-45.
38. Molnar GF, Sailer A, Gunraj CA, et al. Changes in motor cortex excitability with stimulation of anterior thalamus in epilepsy. Neurology 2006;66:566-571.
39. Cantello R, Varrasi C, Tarletti R, et al. Ketogenic diet: electrophysiological effects on the normal human cortex. Epilepsia 2007;48:1756-1763.
40. Kamida T, Fujiki M, Baba H, et al. The relationship between paired pulse magnetic MEP and surgical prognosis in patients with intractable epilepsy. Seizure 2007;16:113-119.
41. Lappchen CH, Feil B, Fauser S, et al. Changes in intracortical excitability after successful epilepsy surgery. Epilepsy Res 2008;79:55-62.